PLI

PEPLIN, INC. - Announcements

0.00%

91.0¢

Currently unlisted.

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

PLI	Suspension from Official Quotation	PRICE SENSITIVE	06/11/09	24.81KB	Share
PLI	Trading halt	PRICE SENSITIVE	06/11/09	449.42KB	Share
PLI	Appendix 4C - quarterly	PRICE SENSITIVE	30/10/09	31.78KB	Share
PLI	LEO Pharma to acquire Peplin for US$287.5m	PRICE SENSITIVE	03/09/09	35.53KB	Share
PLI	Trading Halt	PRICE SENSITIVE	01/09/09	168.17KB	Share
PLI	Preliminary Final Report	PRICE SENSITIVE	31/08/09	51.09KB	Share
PLI	Peplin Completes Enrolment in its Final Phase 3 Trial for AK	PRICE SENSITIVE	19/08/09	25.89KB	Share
PLI	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/09	31.65KB	Share
PLI	Final Phase 3 Clinical Trial for PEP005 Gel in AK Initiated	PRICE SENSITIVE	23/07/09	27.12KB	Share
PLI	Peplin Initiates Phase 3 Trials for PEP005 Gel in AK	PRICE SENSITIVE	09/06/09	28.36KB	Share
PLI	Peplin's Phase II AK Trial Results Published in JAAD	PRICE SENSITIVE	28/05/09	23.86KB	Share
PLI	Positive Results for Peplin's First Phase III AK Trial	PRICE SENSITIVE	18/05/09	42.26KB	Share
PLI	Response to ASX Query re Price	PRICE SENSITIVE	04/05/09	111.13KB	Share
PLI	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/09	31.78KB	Share
PLI	Peplin's Positive Phase IIb AK Trial Result Details	PRICE SENSITIVE	06/03/09	78.79KB	Share
PLI	Half year report	PRICE SENSITIVE	13/02/09	18.06KB	Share
PLI	Appendix 4C - quarterly	PRICE SENSITIVE	09/01/09	32.09KB	Share
PLI	Positive Results for Peplin's Phase IIb AK Trial	PRICE SENSITIVE	08/01/09	31.19KB	Share
PLI	Peplin Completes Enrolment for its First Phase III AK Trial	PRICE SENSITIVE	16/12/08	22.51KB	Share
PLI	Results for Quarter ending 30 September 2008	PRICE SENSITIVE	02/12/08	24.86KB	Share

PLISuspension from Official Quotation
06/11/09	PRICE SENSITIVE	24.81KB	Share
PLITrading halt
06/11/09	PRICE SENSITIVE	449.42KB	Share
PLIAppendix 4C - quarterly
30/10/09	PRICE SENSITIVE	31.78KB	Share
PLILEO Pharma to acquire Peplin for US$287.5m
03/09/09	PRICE SENSITIVE	35.53KB	Share
PLITrading Halt
01/09/09	PRICE SENSITIVE	168.17KB	Share
PLIPreliminary Final Report
31/08/09	PRICE SENSITIVE	51.09KB	Share
PLIPeplin Completes Enrolment in its Final Phase 3 Trial for AK
19/08/09	PRICE SENSITIVE	25.89KB	Share
PLIAppendix 4C - quarterly
31/07/09	PRICE SENSITIVE	31.65KB	Share
PLIFinal Phase 3 Clinical Trial for PEP005 Gel in AK Initiated
23/07/09	PRICE SENSITIVE	27.12KB	Share
PLIPeplin Initiates Phase 3 Trials for PEP005 Gel in AK
09/06/09	PRICE SENSITIVE	28.36KB	Share
PLIPeplin's Phase II AK Trial Results Published in JAAD
28/05/09	PRICE SENSITIVE	23.86KB	Share
PLIPositive Results for Peplin's First Phase III AK Trial
18/05/09	PRICE SENSITIVE	42.26KB	Share
PLIResponse to ASX Query re Price
04/05/09	PRICE SENSITIVE	111.13KB	Share
PLIAppendix 4C - quarterly
30/04/09	PRICE SENSITIVE	31.78KB	Share
PLIPeplin's Positive Phase IIb AK Trial Result Details
06/03/09	PRICE SENSITIVE	78.79KB	Share
PLIHalf year report
13/02/09	PRICE SENSITIVE	18.06KB	Share
PLIAppendix 4C - quarterly
09/01/09	PRICE SENSITIVE	32.09KB	Share
PLIPositive Results for Peplin's Phase IIb AK Trial
08/01/09	PRICE SENSITIVE	31.19KB	Share
PLIPeplin Completes Enrolment for its First Phase III AK Trial
16/12/08	PRICE SENSITIVE	22.51KB	Share
PLIResults for Quarter ending 30 September 2008
02/12/08	PRICE SENSITIVE	24.86KB	Share

REFRESH

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

PEPLIN, INC. - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available